Cargando…

Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection

Detalles Bibliográficos
Autores principales: Lan, Qiaoshuai, Pu, Jing, Cai, Yanxing, Zhou, Jie, Wang, Lijue, Jiao, Fanke, Xu, Wei, Wang, Qian, Xia, Shuai, Lu, Lu, Jiang, Shibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Institut Pasteur. Published by Elsevier Masson SAS. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133820/
https://www.ncbi.nlm.nih.gov/pubmed/34022374
http://dx.doi.org/10.1016/j.micinf.2021.104840
_version_ 1783695126355247104
author Lan, Qiaoshuai
Pu, Jing
Cai, Yanxing
Zhou, Jie
Wang, Lijue
Jiao, Fanke
Xu, Wei
Wang, Qian
Xia, Shuai
Lu, Lu
Jiang, Shibo
author_facet Lan, Qiaoshuai
Pu, Jing
Cai, Yanxing
Zhou, Jie
Wang, Lijue
Jiao, Fanke
Xu, Wei
Wang, Qian
Xia, Shuai
Lu, Lu
Jiang, Shibo
author_sort Lan, Qiaoshuai
collection PubMed
description
format Online
Article
Text
id pubmed-8133820
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Institut Pasteur. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-81338202021-05-20 Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection Lan, Qiaoshuai Pu, Jing Cai, Yanxing Zhou, Jie Wang, Lijue Jiao, Fanke Xu, Wei Wang, Qian Xia, Shuai Lu, Lu Jiang, Shibo Microbes Infect Letter to the Editor Institut Pasteur. Published by Elsevier Masson SAS. 2021 2021-05-20 /pmc/articles/PMC8133820/ /pubmed/34022374 http://dx.doi.org/10.1016/j.micinf.2021.104840 Text en © 2021 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Lan, Qiaoshuai
Pu, Jing
Cai, Yanxing
Zhou, Jie
Wang, Lijue
Jiao, Fanke
Xu, Wei
Wang, Qian
Xia, Shuai
Lu, Lu
Jiang, Shibo
Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection
title Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection
title_full Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection
title_fullStr Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection
title_full_unstemmed Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection
title_short Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection
title_sort lipopeptide-based pan-cov fusion inhibitors potently inhibit hiv-1 infection
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133820/
https://www.ncbi.nlm.nih.gov/pubmed/34022374
http://dx.doi.org/10.1016/j.micinf.2021.104840
work_keys_str_mv AT lanqiaoshuai lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection
AT pujing lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection
AT caiyanxing lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection
AT zhoujie lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection
AT wanglijue lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection
AT jiaofanke lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection
AT xuwei lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection
AT wangqian lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection
AT xiashuai lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection
AT lulu lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection
AT jiangshibo lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection